Argent BioPharma Statistics

Total Valuation

ASX:RGT has a market cap or net worth of AUD 4.87 million. The enterprise value is 12.13 million.

Market Cap	4.87M
Enterprise Value	12.13M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:RGT has 86.94 million shares outstanding. The number of shares has increased by 54.47% in one year.

Current Share Class	84.38M
Shares Outstanding	86.94M
Shares Change (YoY)	+54.47%
Shares Change (QoQ)	+25.65%
Owned by Insiders (%)	28.25%
Owned by Institutions (%)	0.96%
Float	33.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.96
PB Ratio	-0.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.68
EV / Sales	67.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.31

Financial Position

The company has a current ratio of 0.19

Current Ratio	0.19
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.89
Interest Coverage	-304.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-147.52%
Return on Invested Capital (ROIC)	-549.76%
Return on Capital Employed (ROCE)	187.06%
Weighted Average Cost of Capital (WACC)	2.01%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	1.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.17% in the last 52 weeks. The beta is 0.06, so ASX:RGT's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-49.17%
50-Day Moving Average	0.06
200-Day Moving Average	0.09
Relative Strength Index (RSI)	39.85
Average Volume (20 Days)	375,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RGT had revenue of AUD 180,565 and -17.84 million in losses. Loss per share was -0.31.

Revenue	180,565
Gross Profit	-601,038
Operating Income	-15.64M
Pretax Income	-17.84M
Net Income	-17.84M
EBITDA	-15.08M
EBIT	-15.64M
Loss Per Share	-0.31

Full Income Statement

Balance Sheet

The company has 1.02 million in cash and 8.29 million in debt, with a net cash position of -7.26 million or -0.08 per share.

Cash & Cash Equivalents	1.02M
Total Debt	8.29M
Net Cash	-7.26M
Net Cash Per Share	-0.08
Equity (Book Value)	-8.63M
Book Value Per Share	-0.12
Working Capital	-8.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.28 million and capital expenditures -2,231, giving a free cash flow of -9.28 million.

Operating Cash Flow	-9.28M
Capital Expenditures	-2,231
Free Cash Flow	-9.28M
FCF Per Share	-0.11

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-8,663.31%
Pretax Margin	-9,882.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:RGT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.47%
Shareholder Yield	-54.47%
Earnings Yield	-366.51%
FCF Yield	-190.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 30, 2023. It was a reverse split with a ratio of 0.001.

Last Split Date	Oct 30, 2023
Split Type	Reverse
Split Ratio	0.001

Scores

ASX:RGT has an Altman Z-Score of -108.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-108.16
Piotroski F-Score	2